Stoke Therapeutics
(NASDAQ) STOK
Stoke Therapeutics Financials at a Glance
Market Cap
$2.00B
Revenue (TTM)
$184.42M
Net Income (TTM)
$6.88M
EPS (TTM)
$-0.15
P/E Ratio
-227.54
Dividend
$0.00
Beta (Volatility)
1.37 (Average)
Dividend
$0.00
Beta (Volatility)
1.37 (Average)
Price
$33.79
Volume
28,721
Open
$33.38
Price
$33.79
Volume
28,721
Open
$33.38
Previous Close
$33.79
Daily Range
$32.89 - $34.92
52-Week Range
$5.35 - $40.22
Dividend
$0.00
Beta (Volatility)
1.37 (Average)
Price
$33.79
Volume
28,721
Open
$33.38
Previous Close
$33.79
Daily Range
$32.89 - $34.92
52-Week Range
$5.35 - $40.22
STOK News
STOK: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Stoke Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
170
CEO
Ian Frederick Smith, CPA
Website
www.stoketherapeutics.comHeadquarters
Bedford, MA 01730, US
STOK Financials
Key Financial Metrics (TTM)
Gross Margin
99%
Operating Margin
-11%
Net Income Margin
-4%
Return on Equity
-2%
Return on Capital
-6%
Return on Assets
-2%
Earnings Yield
-0.44%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$2.00B
Shares Outstanding
59.15M
Volume
28.72K
Short Interest
0.00%
Avg. Volume
754.46K
Financials (TTM)
Gross Profit
$184.42M
Operating Income
$20.59M
EBITDA
$18.82M
Operating Cash Flow
$45.59M
Capital Expenditure
$670.00K
Free Cash Flow
$44.91M
Cash & ST Invst.
$284.67M
Total Debt
$0.00
Stoke Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.40M
-93.8%
Gross Profit
$347.00K
-98.5%
Gross Margin
24.75%
N/A
Market Cap
$2.00B
N/A
Market Cap/Employee
$15.61M
N/A
Employees
128
N/A
Net Income
$57.93M
-452.7%
EBITDA
$60.38M
-360.0%
Quarterly Fundamentals
Net Cash
$284.67M
+32.7%
Accounts Receivable
$7.91M
+1029.3%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
-100.0%
Return on Assets
-1.65%
N/A
Return on Invested Capital
-5.71%
N/A
Free Cash Flow
$30.69M
-32.1%
Operating Cash Flow
$30.45M
-31.3%